Cardiovascular Events Among Female Users of Osteoporosis Treatments: A Cohort Study in United Kingdom Primary Care Data. [PDF]
Persson R +5 more
europepmc +1 more source
Targeting a Myeloid-Regulatory B Cell Network Reverses Immune Paralysis in Periprosthetic Joint Infections. [PDF]
Wu J +9 more
europepmc +1 more source
Geranylgeraniol as a Modulator of Mevalonate Pathway Disruption: A Scoping Review of Cellular Mechanisms and Skeletal Outcomes in Osteoporosis Models. [PDF]
Ekeuku SO +4 more
europepmc +1 more source
Bilateral atypical femoral fractures following unsupervised long-term alendronate use: a case report. [PDF]
Mianehsaz E +3 more
europepmc +1 more source
Adverse Gastrointestinal Effects of Alendronate Versus Risedronate in Osteoporosis: A Systematic Review and Meta-analysis. [PDF]
Nouh MI +13 more
europepmc +1 more source
Early Metabolic and Oxidative Effects of Hop Extract, Alendronate, and Their Combination Across Tissues in an Estrogen-Deficient Rat Model: An Exploratory Study. [PDF]
Rođak E +6 more
europepmc +1 more source
Pharmacological Interventions for Osteoporosis in Kidney Transplant Recipients: A Systematic Review and Meta-analysis. [PDF]
Wipattanakitcharoen A +5 more
europepmc +1 more source
Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis: A GRADE-assessed systematic review and meta-analysis. [PDF]
Shah A +10 more
europepmc +1 more source
Bushen Huoxue decoction attenuates osteoporosis in ovariectomized rats through suppressing osteoclast differentiation by targeting sirtuin 1 to deactivate nuclear factor-κB. [PDF]
Shuai C +7 more
europepmc +1 more source
The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price. [PDF]
Li E +5 more
europepmc +1 more source

